Trends in Pharmacological Sciences
OpinionHippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
Section snippets
Schizophrenia
Schizophrenia has a prevalence of ∼0.8% of the population and a lifetime prevalence of ∼1% [1]. It is characterized by three classes of signs and symptoms; positive, negative and cognitive. These are initially reported based on whether the sign or symptom was in addition to (positive), or absent from (negative), normal behavior [2]. Thus, positive symptoms of the disease include hallucinations, delusions and disorganized thoughts, whereas negative signs consist of anhedonia and social
Dopamine hypothesis of schizophrenia
The neurotransmitter system that has been most commonly associated with schizophrenia is the dopamine system. This ‘dopamine hypothesis’ is one of the longest-standing hypotheses of schizophrenia. It is based on multiple observations linking dopamine dysregulation to the pathophysiology of the disease. This includes the finding that enhanced activity within the subcortical dopamine system is associated with the positive symptoms of schizophrenia 4, 5 and the fact that all antipsychotic
Altered hippocampal function in schizophrenia
The hippocampus is a temporal lobe structure essential for the consolidation of long-term memories. Deficits in the structure and function of the hippocampus are a consistent observation in imaging and post-mortem studies from schizophrenia patients [14]. Specifically, one of the more constant findings from imaging studies is that patients cannot recruit the hippocampus during a task (i.e. memory recall) 15, 16. Further evidence for hippocampal dysfunction came from structural imaging and
Hippocampal regulation of the function of the dopamine system
The consequence of the purported hippocampal hyperactivity in schizophrenia patients is not entirely known. However, activation of the ventral hippocampus (vHipp) increases dopamine efflux throughout the nucleus accumbens (NAc) of anesthetized rats 26, 27. Thus, chemical or electrical stimulation of the vHipp produces sustained increases in extrasynaptic dopamine throughout the NAc, a principal target of dopamine neurons 26, 27. The mechanisms underlying these effects were not immediately
Depolarization block hypothesis of antipsychotic medications
All current antipsychotic medications have antagonist actions at the dopamine D2 receptor. However, it is evident that antipsychotic drugs achieve their effects via mechanisms that are more complex than the simple blockade of dopamine receptors. Thus, although the maximum rate of improvement occurs early in treatment 38, 39, 40, 41, patients also require several weeks of treatment to reach maximum therapeutic responses [38] without evidence of tolerance (as one would expect from simple receptor
The hippocampus as a novel therapeutic target
Although conventional antipsychotic medications might effectively decrease the positive symptoms of schizophrenia, they are not particularly effective at treating negative signs and cognitive symptoms. This largely reflects the mechanism of action of D2 antagonists. A decrease in dopamine neuron population activity due to depolarization block will reduce the ascribed salience of the dopamine signal. However, it achieves this not by reversing the proposed vHipp overdrive, but instead by inducing
Concluding remarks
There is increasing evidence from preclinical and human imaging studies suggesting that augmented hippocampal function secondary to a loss of interneuron function underlies the dopamine hyperfunction associated with psychosis in schizophrenia. Thus, restoration of hippocampal function might provide a novel therapeutic target for treatment of the disease. Indeed, our recent data demonstrate that a positive allosteric modulator of the α5GABAA receptor can reverse aberrant dopamine system function
Acknowledgments
Dr. Grace has the following financial disclosures: Johnson & Johnson, Lundbeck, Pfizer, GSK, Puretech Ventures, Merck, Takeda, and Dainippon Sumitomo. Dr. Lodge has no conflicts of interest to report.
References (64)
Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia
Biol. Psychiatry
(2003)SPECT study of visual fixation in schizophrenia and comparison subjects
Biol. Psychiatry
(1999)Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia
Psychiatry Res. – Neuroimaging
(2003)- et al.
Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia
Behav. Brain Res.
(2009) A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia
Biol. Psychiatry
(2006)Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended
Biol. Psychiatry
(2005)- et al.
Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity
Life Sci.
(1978) Haloperidol does not produce dopamine cell depolarization-block in paralyzed, unanesthetized rats
Brain Res.
(1998)GABAA receptor subtypes: Dissecting their pharmacological functions
Trends Pharmacol. Sci.
(2001)Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at [alpha]1 plus [alpha]5 versus [alpha]2 plus [alpha]3 subunits account for dissimilarities in behavioral effects in rats?
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(2010)